Medical Equipment

Biopsy Needle Market Forecast 2026: Where the Industry Is Headed

January 30, 2026January 30, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the nicotinamide adenine dinucleotide market from 2026–2035 with trusted insights from The Business Research Company

What was the valuation of the Biopsy Needle Market in 2026, and what figure is it projected to hit by 2030?

The biopsy needle market has experienced robust expansion in recent years. Its projected growth is from $1.41 billion in 2025 to reach $1.52 billion in 2026, at a compound annual growth rate (CAGR) of 7.8%. Historically, this expansion has been influenced by factors such as a reliance on traditional core needle biopsy methods, the limited availability of vacuum-assisted biopsy devices, a growing prevalence of cancer cases, increasing hospital and surgical center infrastructure, and rising awareness of early diagnostic procedures.

The biopsy needle market is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $2.06 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.9%. This growth during the forecast timeframe is primarily driven by various factors, including technological progress in image-guided and vacuum-assisted devices, the creation of novel disposable needle designs, the increasing number of diagnostic clinics and pathology laboratories, greater funding for research and academic institutions, and the incorporation of AI and digital instruments for accurate diagnostics. Key trends anticipated during this period encompass a wider embrace of image-guided biopsy techniques, a growing inclination towards disposable biopsy needles, the rise of minimally invasive diagnostic methods, an increase in cancer and tumor screening initiatives, and a stronger emphasis on patient safety and sterility protocols.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27224&type=smp

Which Drivers Are Affecting Market Participation In The Biopsy Needle Market?

The escalating demand for less invasive medical interventions is anticipated to fuel the expansion of the biopsy needle market moving forward. Less invasive procedures involve medical treatments performed via small cuts or openings, thereby lessening patient trauma and speeding up recovery. The preference for minimally invasive surgical methods is increasing because they offer quicker healing periods, lower risks of complications, reduced pain, and smaller scars, making them more desirable for patients seeking rapid and secure treatment options. Biopsy needles facilitate minimally invasive procedures by enabling precise tissue collection, diminishing the necessity for surgical intervention. They support prompt diagnoses and shorter recovery times, enhancing patient comfort and the efficiency of procedures. For instance, in November 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, the total number of cosmetic minimally invasive procedures reached 25,442,640 in 2023, marking a 7% increase from 23,672,269 in 2022. Thus, the rising demand for minimally invasive procedures is a key driver for the growth of the biopsy needle market.

What Segment Classifications Make Up The Biopsy Needle Market?

The biopsy needle market covered in this report is segmented –

1) By Usage: Disposable, Non-Disposable

2) By Product: Needle Based Biopsy Guns, Vacuum-Assisted Biopsy Devices, Fine Needle Aspiration Biopsy Devices, Core Needle Biopsy Devices

3) By Procedure: Image-Guided Procedures, Non-Image-Guided Procedures

4) By Application: Cancer Or Tumor, Breast, Lung, Prostate, Colon, Stomach, Liver, Rectum, Cervix Uteri, Other Applications

5) By End-User: Hospitals And Surgical Centers, Diagnostic Clinics And Pathology Laboratories, Ambulatory Care Centers, Research And Academic Institutes

Subsegments:

1) By Disposable: Coaxial Biopsy Needles, Chiba Needles, Jamshidi Needles

2) By Non-Disposable: Reusable Tru-Cut Biopsy Needles, Reusable Menghini Needles, Reusable Francine Needles

What Upcoming Trends Are Likely To Define The Future Path Of The Biopsy Needle Market?

Major companies operating in the biopsy needle market are concentrating on developing advanced technological products, such as semi-automatic core biopsy instruments, to improve the accuracy and ease of tissue sampling in minimally invasive procedures. Semi-automatic core biopsy instruments are medical tools that utilize a spring-loaded mechanism to efficiently and accurately gather tissue samples with reduced manual effort during a biopsy. For instance, in May 2023, Argon Medical Devices Inc., a US-based medical device manufacturer, unveiled the SuperCore Advantage semi-automatic biopsy instrument. This is a semi-automatic, disposable core biopsy needle designed to yield consistent, high-quality tissue samples crucial for precise diagnoses. It features an ergonomic design, a sharp cutting edge for clean specimen retrieval, and an adjustable throw length to suit various lesion depths. The device also enhances biopsy precision while diminishing patient discomfort, thus offering better diagnostic options for patients.

Which Key Players Are Driving Competition In The Biopsy Needle Market?

Major companies operating in the biopsy needle market are Cardinal Health Inc., Medtronic plc, Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Hologic Inc., Cook Medical, Halma plc, Merit Medical Systems Inc., ConMed Corporation, Devicor Medical Products Inc., Shandong Weigao Group Medical Polymer Company Limited, Remington Medical Inc., Advin Health Care, Nikotech Healthcare Pvt. Ltd., Argon Medical Devices Inc., Geotek Medical Products Co. Ltd., Biomedical Srl, Hakko Co. Ltd., INRAD Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/biopsy-needle-global-market-report

Which Region Is Projected To Lead The Biopsy Needle Market During The Forecast Period?

North America was the largest region in the biopsy needle market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopsy needle market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Biopsy Needle Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27224&type=smp

Browse Through More Reports Similar to the Global Biopsy Needle Market 2026, By The Business Research Company

Building And Construction Glass Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/building-and-construction-glass-global-market-report

Green Building Materials Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/green-building-materials-global-market-report

Construction Glass Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/construction-glass-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795